Patients with thalassemia in the Gaza Strip are facing critical shortages of medicine and treatment due to an escalating humanitarian crisis [1, 2].
This medical scarcity threatens the lives of individuals requiring regular blood transfusions and specialized care, as the collapse of health infrastructure makes chronic disease management nearly impossible.
Medical supplies have dwindled following the destruction of infrastructure and the loss of consistent electricity and water services [1, 2]. These conditions are exacerbated by a prolonged blockade that limits the entry of essential pharmaceuticals and medical equipment into the territory [1, 2].
Reports indicate that the humanitarian situation remains dire, with tens of thousands of people living in tents across the strip [3]. The lack of sterile environments and reliable power sources creates additional risks for patients who are already immunocompromised.
To address these challenges, the Thalassemia Patients' Friends Association organized a scientific day in Gaza. The event aimed to highlight the specific health and psychological burdens facing those living with the blood disorder [2].
"The Thalassemia Patients' Friends Association organized a scientific day in Gaza to shed light on the health and psychological challenges for thalassemia patients," the association said [2].
These struggles persist even 62 days after a ceasefire was established [3]. The gap between the cessation of active combat and the restoration of basic healthcare services has left thousands of patients in a state of medical limbo.
“Patients with thalassemia in the Gaza Strip are facing critical shortages of medicine and treatment.”
The crisis for thalassemia patients illustrates the long-term systemic collapse of Gaza's healthcare system. Because thalassemia requires lifelong, consistent medical intervention, the transition from active conflict to a precarious ceasefire does not automatically restore health security. The reliance on temporary shelters and the absence of a functional medical supply chain mean that treatable chronic conditions are becoming fatal, shifting the crisis from acute war casualties to a slow-motion public health catastrophe.
